• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便免疫化学试验完成时间用于结直肠癌筛查。

Time to fecal immunochemical test completion for colorectal cancer screening.

机构信息

Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave, Ste 1600, Seattle, WA 98101. Email:

出版信息

Am J Manag Care. 2019 Apr;25(4):174-180.

PMID:30986014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7170013/
Abstract

OBJECTIVES

Fecal immunochemical tests (FITs) can efficiently screen for colorectal cancer (CRC), but little is known on the timing to their completion. We investigate the time to return of a FIT following an order and describe patient characteristics associated with FIT return.

STUDY DESIGN

Retrospective cohort study.

METHODS

We identified 63,478 members of Kaiser Permanente Washington, aged 50 to 74 years, who received a FIT order from 2011 through 2012. Patient characteristics were ascertained through administrative and electronic health record data sources. We compared time from FIT order to return by patient characteristics using Kaplan-Meier and Cox regression methods.

RESULTS

About half (53.7%) of members completed a FIT. Median time from order to return was 13 days (mean, 44.5 days; interquartile range, 6-42 days). There was higher completion of FITs among Asian patients (hazard ratio [HR], 1.43; 95% CI, 1.38-1.48), black patients (HR, 1.13; 95% CI, 1.08-1.19), and Hispanic patients (HR, 1.10; 95% CI, 1.04-1.16) compared with white patients; among patients with recent CRC testing (vs no testing in past 2 years; HR, 1.90; 95% CI, 1.86-1.95); and among patients with Medicare insurance (vs commercial; HR, 1.30; 95% CI, 1.24-1.37). Factors associated with decreased FIT completion included younger age (50-54 years vs 70-74 years; HR, 0.87; 95% CI, 0.82-0.92), obesity (vs normal body mass index; HR, 0.88; 95% CI, 0.86-0.91), and higher Charlson Comorbidity Index score (≥3 vs 0; HR, 0.82; 95% CI, 0.79-0.87).

CONCLUSIONS

Time to return of FIT varies by patient characteristics. We observed greater FIT completion among people of color, suggesting that racial disparities in CRC may not be due to patient completion of the test after an order is received.

摘要

目的

粪便免疫化学检测(FIT)可有效地筛查结直肠癌(CRC),但对于完成检测所需的时间知之甚少。本研究旨在探讨 FIT 检测完成的时间,并描述与 FIT 检测回报相关的患者特征。

研究设计

回顾性队列研究。

方法

我们纳入了 Kaiser Permanente Washington 的 63478 名年龄在 50 至 74 岁之间的成员,这些成员在 2011 年至 2012 年期间接受了 FIT 检测。通过行政和电子健康记录数据源确定患者特征。我们通过 Kaplan-Meier 和 Cox 回归方法比较了不同患者特征下从 FIT 检测订单到回报的时间。

结果

约有一半(53.7%)的成员完成了 FIT 检测。从订单到回报的中位时间为 13 天(平均 44.5 天;四分位间距为 6-42 天)。与白人患者相比,亚洲患者(HR,1.43;95%CI,1.38-1.48)、黑人患者(HR,1.13;95%CI,1.08-1.19)和西班牙裔患者(HR,1.10;95%CI,1.04-1.16)完成 FIT 检测的比例更高;与过去 2 年内未进行 CRC 检测的患者相比(HR,1.90;95%CI,1.86-1.95);与拥有医疗保险的患者相比(HR,1.30;95%CI,1.24-1.37)。与 FIT 检测完成率降低相关的因素包括年龄较小(50-54 岁 vs 70-74 岁;HR,0.87;95%CI,0.82-0.92)、肥胖(HR,0.88;95%CI,0.86-0.91)和较高的 Charlson 合并症指数评分(≥3 分 vs 0 分;HR,0.82;95%CI,0.79-0.87)。

结论

FIT 检测完成的时间因患者特征而异。我们观察到有色人种的 FIT 检测完成率更高,这表明 CRC 中的种族差异可能不是由于患者在收到检测订单后完成了检测。

相似文献

1
Time to fecal immunochemical test completion for colorectal cancer screening.粪便免疫化学试验完成时间用于结直肠癌筛查。
Am J Manag Care. 2019 Apr;25(4):174-180.
2
"Finding the Right FIT": Rural Patient Preferences for Fecal Immunochemical Test (FIT) Characteristics.“找到合适的匹配度”:农村患者对粪便免疫化学检测(FIT)特征的偏好
J Am Board Fam Med. 2017 Sep-Oct;30(5):632-644. doi: 10.3122/jabfm.2017.05.170151.
3
Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.结肠镜检查外展与粪便免疫化学检测外展对结直肠癌筛查完成率的影响:一项随机临床试验。
JAMA. 2017 Sep 5;318(9):806-815. doi: 10.1001/jama.2017.11389.
4
Disparities in Colorectal Cancer Screening Practices in a Midwest Urban Safety-Net Healthcare System.中西部城市医保系统中结直肠癌筛查实践的差异。
Dig Dis Sci. 2021 Aug;66(8):2585-2594. doi: 10.1007/s10620-020-06545-3. Epub 2020 Aug 20.
5
Participant uptake of the fecal immunochemical test decreases with the two-sample regimen compared with one-sample FIT.与单样本粪便免疫化学检测相比,采用两样本方案时参与者对粪便免疫化学检测的接受度会降低。
Eur J Cancer Prev. 2014 Nov;23(6):516-23. doi: 10.1097/CEJ.0000000000000084.
6
Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.种族和社会经济地位与美国南部成年人结直肠癌筛查、结直肠癌风险和死亡率的关联。
JAMA Netw Open. 2019 Dec 2;2(12):e1917995. doi: 10.1001/jamanetworkopen.2019.17995.
7
Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.在服务不足人群中提高结直肠癌筛查率的粪便免疫化学试验外展、结肠镜外展与常规护理的效果比较:一项随机临床试验。
JAMA Intern Med. 2013 Oct 14;173(18):1725-32. doi: 10.1001/jamainternmed.2013.9294.
8
Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.影响年度粪便免疫化学试验用于结直肠癌的实用临床试验依从性的因素。
J Gen Intern Med. 2019 Jun;34(6):978-985. doi: 10.1007/s11606-018-4820-0. Epub 2019 Jan 25.
9
Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.粪便免疫化学检测(FIT)和结肠镜检查的外展邀请可提高结直肠癌筛查率:一项在安全网医疗系统中的随机对照试验。
Cancer. 2016 Feb 1;122(3):456-63. doi: 10.1002/cncr.29770. Epub 2015 Nov 4.
10
Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.在符合筛查条件的美国成年人中,使用粪便潜血试验/粪便免疫化学试验进行结直肠癌筛查,医生办公室与家庭的接受率比较。
Cancer Med. 2019 Dec;8(17):7408-7418. doi: 10.1002/cam4.2604. Epub 2019 Oct 21.

引用本文的文献

1
Fecal Immunochemical Test Completion by Instruction Type: A Randomized Clinical Trial Comparing Quick Response Code-Linked Video to Pictorial Instructions.按指导类型完成粪便免疫化学检测:一项将二维码链接视频与图片说明进行比较的随机临床试验
Am J Gastroenterol. 2025 Jul 7. doi: 10.14309/ajg.0000000000003637.
2
Adherence to Repeat Screening Completion for Colorectal Cancer Using the Multi-Target Stool DNA Test: Real-World Analysis of Patients from Federally Qualified Health Centers.使用多靶点粪便DNA检测坚持完成结直肠癌重复筛查:对来自联邦合格健康中心患者的真实世界分析
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251348099. doi: 10.1177/21501319251348099. Epub 2025 Jun 17.
3

本文引用的文献

1
Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program.50 岁以上人群在组织化项目中进行结直肠癌筛查的启动。
Am J Prev Med. 2017 Sep;53(3):335-344. doi: 10.1016/j.amepre.2017.02.018. Epub 2017 Apr 17.
2
The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment.美国预防服务工作组2017年关于前列腺癌筛查的建议声明草案:邀请审查与评论。
JAMA. 2017 May 16;317(19):1949-1950. doi: 10.1001/jama.2017.4413.
3
Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.
Effectiveness and Acceptability of Targeted Text Message Reminders in Colorectal Cancer Screening: Randomized Controlled Trial (M-TICS Study).
靶向短信提醒在结直肠癌筛查中的有效性和可接受性:随机对照试验(M-TICS 研究)。
JMIR Public Health Surveill. 2024 Jul 31;10:e57959. doi: 10.2196/57959.
4
Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45-49-year-old community health center population.邮寄粪便免疫化学试验(FIT)外展后,新纳入的 45-49 岁社区卫生中心人群中结直肠癌筛查的参与情况。
Cancer Causes Control. 2023 Dec;34(Suppl 1):125-133. doi: 10.1007/s10552-023-01717-8. Epub 2023 Jun 10.
5
Video brochures in a mailed fecal immunochemical test outreach program provide cancer screening information in a user-friendly format for rural Appalachian community members.邮寄粪便免疫化学检测外展项目中的视频宣传册以用户友好的格式为阿巴拉契亚农村社区成员提供癌症筛查信息。
J Rural Health. 2024 Jan;40(1):96-103. doi: 10.1111/jrh.12772. Epub 2023 Jun 9.
6
Faecal immunochemical test for suspected colorectal cancer symptoms: patient survey of usability and acceptability.针对疑似结直肠癌症状的粪便免疫化学检测:患者对可用性和可接受性的调查
BJGP Open. 2022 Mar 22;6(1). doi: 10.3399/BJGPO.2021.0102. Print 2022 Mar.
7
The influence of multi-morbidities on colorectal cancer screening recommendations and completion.多种合并症对结直肠癌筛查建议和完成情况的影响。
Cancer Causes Control. 2021 May;32(5):555-565. doi: 10.1007/s10552-021-01408-2. Epub 2021 Mar 9.
结直肠癌筛查策略的益处、负担及危害评估:美国预防服务工作组的建模研究
JAMA. 2016 Jun 21;315(23):2595-609. doi: 10.1001/jama.2016.6828.
4
Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.结直肠癌筛查:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2016 Jun 21;315(23):2576-94. doi: 10.1001/jama.2016.3332.
5
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.结直肠癌筛查:美国预防服务工作组推荐声明。
JAMA. 2016 Jun 21;315(23):2564-2575. doi: 10.1001/jama.2016.5989.
6
Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems.不同医疗系统中结直肠癌筛查的种族/族裔差异。
Am J Prev Med. 2016 Oct;51(4):e107-15. doi: 10.1016/j.amepre.2016.02.025. Epub 2016 Apr 1.
7
How many individuals will need to be screened to increase colorectal cancer screening prevalence to 80% by 2018?要使 2018 年结直肠癌筛查普及率提高到 80%,需要对多少人进行筛查?
Cancer. 2015 Dec 1;121(23):4258-65. doi: 10.1002/cncr.29659. Epub 2015 Aug 26.
8
Colorectal Cancer Screening in Switzerland: Cross-Sectional Trends (2007-2012) in Socioeconomic Disparities.瑞士的结直肠癌筛查:社会经济差异的横断面趋势(2007 - 2012年)
PLoS One. 2015 Jul 6;10(7):e0131205. doi: 10.1371/journal.pone.0131205. eCollection 2015.
9
A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.新一代粪便免疫化学检测(FIT)在结肠镜检查转诊患者中检测结直肠肿瘤方面优于基于愈创木脂的检测。
Anticancer Res. 2015 May;35(5):2873-80.
10
The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration.健康维护组织研究网络虚拟数据仓库:支持协作的公共数据模型。
EGEMS (Wash DC). 2014 Mar 24;2(1):1049. doi: 10.13063/2327-9214.1049. eCollection 2014.